Prof Pollack speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about the repurposing of metformin to treat cancer.
Metformin is a widely used treatment for type II diabetes, but has also been reported to slow tumour cell proliferation through the inhibition of the mTOR pathway.
Prof Pollack describes the clinical and regulatory background of repurposing metformin and other drugs for new avenues of research.
